Chrystal Louis
Förmögenhet: - $ per 2026-07-31
Förmögenhet: - $ per 2026-07-31
Chrystal U.
Louis is currently Chief Medical Officer at TScan Therapeutics, Inc. since 2024.
Formerly, Dr. Louis was Senior VP-Hematology Clinical Development at Zentalis Pharmaceuticals, Inc. from 2022 to 2024, Vice President & Head-Medical Affairs at CRISPR Therapeutics, Inc. from 2020 to 2022, and Executive Director-Myeloid Diseases at Celgene Corp.
from 2018 to 2019.
Education includes graduate and doctorate degrees from Tulane University School of Medicine and an undergraduate degree from Southwestern University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-04-08 |
| Företag | Position | Slut |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Företagsledare/Principal | 2024-03-01 |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Företagsledare/Principal | 2022-11-01 |
| CELGENE | Företagsledare/Principal | 2019-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Southwestern University
Southwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University School of Medicine
Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån